
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
Chemed Corp (CHE)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: CHE (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $567.25
1 Year Target Price $567.25
2 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.66% | Avg. Invested days 49 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.47B USD | Price to earnings Ratio 22.87 | 1Y Target Price 567.25 |
Price to earnings Ratio 22.87 | 1Y Target Price 567.25 | ||
Volume (30-day avg) 3 | Beta 0.46 | 52 Weeks Range 407.86 - 622.21 | Updated Date 08/14/2025 |
52 Weeks Range 407.86 - 622.21 | Updated Date 08/14/2025 | ||
Dividends yield (FY) 0.44% | Basic EPS (TTM) 19.41 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-07-22 | When Before Market | Estimate 6.04 | Actual 4.27 |
Profitability
Profit Margin 11.56% | Operating Margin (TTM) 11% |
Management Effectiveness
Return on Assets (TTM) 13.56% | Return on Equity (TTM) 24.14% |
Valuation
Trailing PE 22.87 | Forward PE 19.92 | Enterprise Value 6458165560 | Price to Sales(TTM) 2.57 |
Enterprise Value 6458165560 | Price to Sales(TTM) 2.57 | ||
Enterprise Value to Revenue 2.57 | Enterprise Value to EBITDA 14.24 | Shares Outstanding 14571700 | Shares Floating 14283352 |
Shares Outstanding 14571700 | Shares Floating 14283352 | ||
Percent Insiders 1.97 | Percent Institutions 95.99 |
Upturn AI SWOT
Chemed Corp
Company Overview
History and Background
Chemed Corp was founded in 1971. Initially focused on various services, it evolved to concentrate on hospice and palliative care, primarily through its Vitas Healthcare subsidiary. It also has a presence in the plumbing services industry through Roto-Rooter.
Core Business Areas
- Vitas Healthcare: Provides hospice and palliative care services to patients with terminal illnesses. This segment is a significant revenue driver for Chemed.
- Roto-Rooter: Offers plumbing, drain cleaning, and water restoration services for residential and commercial customers.
Leadership and Structure
Chemed Corp is led by CEO Kevin McNamara. The company has a board of directors overseeing its operations. The organizational structure is divided into the Vitas and Roto-Rooter segments, each with its own management team.
Top Products and Market Share
Key Offerings
- Hospice Care (Vitas): Comprehensive hospice care services including medical, emotional, and spiritual support for terminally ill patients and their families. Vitas is one of the largest hospice providers in the US. Market share data varies, but they are a top player. Competitors include Gentiva, Amedisys (AMED), LHC Group, and AccentCare.
- Plumbing Services (Roto-Rooter): Plumbing, drain cleaning, and water restoration services. Roto-Rooter holds a significant share of the market. Competitors include Mr. Rooter, Benjamin Franklin Plumbing, and local plumbing services.
Market Dynamics
Industry Overview
The hospice care industry is growing due to the aging population and increasing acceptance of hospice as an end-of-life care option. The plumbing services industry is stable, driven by ongoing maintenance and repair needs.
Positioning
Chemed Corp is a leader in the hospice care market through Vitas, known for its comprehensive services and established network. Roto-Rooter benefits from its brand recognition and national footprint in the plumbing services sector.
Total Addressable Market (TAM)
The hospice care TAM is estimated to be in the tens of billions of dollars and is projected to continue growing as the US population ages. The plumbing services TAM is also substantial and stable, measured in billions of dollars. Chemed is well-positioned in both markets to address this TAM.
Upturn SWOT Analysis
Strengths
- Strong market position in hospice care (Vitas)
- Recognizable brand name in plumbing services (Roto-Rooter)
- Diversified revenue streams
- Experienced management team
- National presence
Weaknesses
- Regulatory scrutiny in the hospice industry
- Labor shortages in healthcare and plumbing
- Dependence on government reimbursement rates
- Exposure to economic downturns impacting plumbing demand
- Potential for negative publicity
Opportunities
- Expansion of hospice services into underserved areas
- Acquisitions of smaller hospice providers
- Technological advancements in plumbing diagnostics and repair
- Partnerships with healthcare providers and insurance companies
- Growing demand for water restoration services
Threats
- Changes in government reimbursement policies
- Increased competition in the hospice and plumbing markets
- Rising labor costs
- Economic downturn impacting demand for plumbing services
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- AMED
- GNTX
- RNR
Competitive Landscape
Chemed holds a competitive advantage through its established presence in hospice and plumbing. Their competitive advantages need to be continuously monitored and adapted to changes in the business world.
Major Acquisitions
Rose Group International
- Year: 2019
- Acquisition Price (USD millions): 124
- Strategic Rationale: Expansion of Roto-Rooter services
Growth Trajectory and Initiatives
Historical Growth: Chemed has demonstrated growth through organic expansion and strategic acquisitions.
Future Projections: Future growth projections can be gathered from analyst estimates. It hinges on the growth of the hospice and plumbing markets.
Recent Initiatives: Chemed focuses on operational efficiency and market expansion across both of their business lines. Recent initiatives require real-time research.
Summary
Chemed Corp is a fairly strong company with a dual focus on hospice care and plumbing services. Vitas Healthcare is a substantial revenue driver, while Roto-Rooter offers stability. Regulatory scrutiny and labor shortages represent ongoing challenges. Chemed must remain adaptable to sustain its growth in both markets.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Investor Relations
- Market Research Reports
- Analyst Reports
Disclaimers:
The analysis provided is based on available information and is subject to change. It does not constitute financial advice. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Chemed Corp
Exchange NYSE | Headquaters Cincinnati, OH, United States | ||
IPO Launch date 1973-05-03 | CEO, President & Director Mr. Kevin J. McNamara | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 15695 | Website https://www.chemed.com |
Full time employees 15695 | Website https://www.chemed.com |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.